Si è verificato un errore durante il caricamento della pagina.
Il nostro team è stato avvisato ma contattaci tramite il Widget assistenza email se il problema persiste.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBITDA Multiple | 17,7x - 19,6x | 18,7x |
Selected Fwd EBITDA Multiple | 12,6x - 14,0x | 13,3x |
Fair Value | ﷼149,20 - ﷼164,85 | ﷼157,02 |
Upside | -14,3% - -5,3% | -9,8% |
Benchmarks | Ticker | Full Ticker |
Mouwasat Medical Services Company | 4002 | SASE:4002 |
Al Hammadi Holding Company | 4007 | SASE:4007 |
Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
Middle East Healthcare Company | 4009 | SASE:4009 |
Dr. Soliman Abdel Kader Fakeeh Hospital Company | 4017 | SASE:4017 |
National Medical Care Company | 4005 | SASE:4005 |
- | - | - |
Select LTM EBITDA Multiple | |||||||
Benchmark Companies | |||||||
4002 | 4007 | 4013 | 4009 | 4017 | 4005 | ||
SASE:4002 | SASE:4007 | SASE:4013 | SASE:4009 | SASE:4017 | SASE:4005 | ||
Historical EBITDA Growth | |||||||
5Y CAGR | 9.4% | 10.5% | 20.3% | 26.1% | 5.9% | 14.9% | |
3Y CAGR | 7.3% | 19.5% | 16.2% | 50.3% | 1.7% | 13.7% | |
Latest Twelve Months | 2.2% | -3.4% | 21.8% | 8.3% | -5.1% | 16.5% | |
Historical EBITDA Profit Margin | |||||||
5 Year Average Margin | 35.5% | 31.2% | 24.0% | 15.5% | 18.5% | 25.0% | |
Prior Fiscal Year | 36.0% | 36.7% | 24.8% | 18.8% | 18.4% | 26.9% | |
Latest Fiscal Year | 33.2% | 34.0% | 24.2% | 21.8% | 16.5% | 24.4% | |
Latest Twelve Months | 33.3% | 31.4% | 23.8% | 21.0% | 15.0% | 25.1% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 5.20x | 4.43x | 7.59x | 2.57x | 3.36x | 5.31x | |
EV / LTM EBITDA | 15.6x | 14.1x | 31.8x | 12.3x | 22.4x | 21.2x | |
EV / LTM EBIT | 20.5x | 18.1x | 38.1x | 18.0x | 29.7x | 26.3x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBITDA | 12.3x | 15.6x | 31.8x | ||||
Historical EV / LTM EBITDA | 12.5x | 14.5x | 25.0x | ||||
Selected EV / LTM EBITDA | 17.7x | 18.7x | 19.6x | ||||
(x) LTM EBITDA | 372 | 372 | 372 | ||||
(=) Implied Enterprise Value | 6,593 | 6,940 | 7,287 | ||||
(-) Non-shareholder Claims * | 23 | 23 | 23 | ||||
(=) Equity Value | 6,617 | 6,964 | 7,311 | ||||
(/) Shares Outstanding | 44.7 | 44.7 | 44.7 | ||||
Implied Value Range | 148.05 | 155.82 | 163.58 | ||||
FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
Implied Value Range (Trading Cur) | 148.05 | 155.82 | 163.58 | 174.00 | |||
Upside / (Downside) | -14.9% | -10.4% | -6.0% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | 4002 | 4007 | 4013 | 4009 | 4017 | 4005 | |
Enterprise Value | 15,714 | 5,322 | 95,469 | 7,650 | 9,964 | 7,753 | |
(+) Cash & Short Term Investments | 326 | 194 | 2,185 | 32 | 277 | 477 | |
(+) Investments & Other | 0 | 147 | 473 | 69 | 197 | 0 | |
(-) Debt | (954) | (287) | (9,034) | (2,419) | (1,074) | (454) | |
(-) Other Liabilities | (136) | 0 | (472) | (53) | (394) | 0 | |
(-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 14,950 | 5,376 | 88,620 | 5,278 | 8,970 | 7,776 | |
(/) Shares Outstanding | 200.0 | 160.0 | 350.0 | 92.0 | 230.0 | 44.7 | |
Implied Stock Price | 74.75 | 33.60 | 253.20 | 57.35 | 39.00 | 174.00 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 74.75 | 33.60 | 253.20 | 57.35 | 39.00 | 174.00 | |
Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |